Recipharm AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.11.16	Recipharm AB: Interim report January-September 2016 (Businesswire)
07.11.16	Invitation to Presentation of Recipharm’s Interim Report for the Third Quarter 2016 on the 10th November (Businesswire)
29.09.16	Recipharm Successfully Places SEK 1,000M Senior Unsecured Convertible Bonds (Businesswire)
29.09.16	Recipharm AB: Recipharm launches a senior unsecured convertible bond issue of approximately SEK 1,000m (Businesswire)
22.07.16	Recipharm AB: Interim report January-June 2016 (Businesswire)
18.07.16	Invitation to Presentation of Recipharm’s Interim Report for the Second Quarter 2016 on the 22nd July (Businesswire)
30.06.16	Change in the total number of shares and votes in Recipharm AB (publ) (Businesswire)
13.06.16	Recipharm’s Rights Issue Fully Subscribed (Businesswire)
31.05.16	Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
23.05.16	Recipharm AB: Recipharm completes acquisition of Kemwell AB and Cirrus Pharmaceuticals Inc. and resolve on share issues (Businesswire)
18.05.16	The Board of Directors of Recipharm resolves on a rights issue of approximately SEK 805 million and announces terms (Businesswire)
11.05.16	Bulletin from Extraordinary General Meeting of Recipharm AB (Publ) (Businesswire)
29.04.16	Bulletin from Annual General Meeting in Recipharm AB (publ) (Businesswire)
28.04.16	Recipharm AB: Interim report January-March 2016 (Businesswire)
26.04.16	Recipharm AB: Invitation to presentation of Recipharm’s interim report for the first quarter 2016 on the 28th April (Businesswire)
18.04.16	Notice to Attend the Extra Ordinary General Meeting of Recipharm AB (publ) (Businesswire)
18.04.16	Recipharm AB: Recipharm creates a global CDMO leader through SEK 1.7 billion strategic acquisitions in the US, Sweden and India (Businesswire)
11.04.16	Recipharm AB: Recipharm completes acquisition of a majority stake in Indian CMO Nitin Lifesciences (Businesswire)
05.04.16	Recipharm AB: Recipharm Publishes Annual Report 2015 (Businesswire)
31.03.16	Change in the total number of shares and votes in Recipharm AB (publ) (Businesswire)
30.03.16	Notice to attend the Annual General Meeting of Recipharm AB (Publ) (Businesswire)
03.03.16	Recipharm AB: Announcement from the Nomination Committee Concerning the Annual General Meeting 2016 (Businesswire)
29.02.16	Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
24.02.16	Recipharm AB: Full Year report January - December 2015 (Businesswire)
23.02.16	Recipharm AB: Recipharm to acquire Mitim Srl for SEK 640 million adding scale and niche technology in injectable beta lactams (Businesswire)
22.02.16	Recipharm AB: Invitation to Presentation of Recipharm’s Full Year Report for 2015 on the 24th February (Businesswire)
26.01.16	Recipharm AB: Recipharm completes a directed issue of 2.25 million Class B shares, raising proceeds of approximately SEK 276 million (Businesswire)
15.01.16	Recipharm AB: Regulatory approval received for acquisition of Nitin Lifesciences (Businesswire)
21.12.15	Recipharm Signs Manufacturing Agreement with Alcon and Acquires Facility in France, Adding New Niche Capabilities (Businesswire)
05.11.15	Recipharm AB: Interim Report January - September 2015 (Businesswire)
03.11.15	Recipharm AB: Invitation to presentation of Recipharm’s interim report for the third quarter on 5 November 2015 (Businesswire)
20.10.15	Recipharm to Acquire Majority Stake in Indian CMO Nitin Lifesciences Creating Emerging Markets Platform (Businesswire)
08.10.15	Recipharm AB: Recipharm announces cost and efficiency program in Sweden (Businesswire)
07.09.15	Recipharm In Discussions with Alcon Regarding Long-Term Manufacturing Agreement (Businesswire)
31.07.15	Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
23.07.15	Recipharm AB: Interim Report January-June 2015 (Businesswire)
30.06.15	Change in the Total Number of Shares and Votes in Recipharm AB (publ) (Businesswire)
15.06.15	Recipharm Acquires OnTarget Chemistry and Extends Its Offering into Preclinical Development Services (Businesswire)
01.06.15	Recipharm AB: Recipharm appoints Chief Strategy Officer (Businesswire)
07.05.15	Recipharm AB: Interim Report January-March 2015 (Businesswire)
04.05.15	Recipharm AB: Invitation to Presentation of Recipharm’s Interim Report for the First Quarter on 7 May 2015 (Businesswire)
16.04.15	Recipharm AB: Recipharm Publishes Annual Report 2014 (Businesswire)
14.04.15	Recipharm Makes Strategic Investment in Synthonics and Partners in Development of Novel Compounds (Businesswire)
08.04.15	Notice to Attend the Annual General Meeting of Recipharm AB (Publ) (Businesswire)
08.04.15	Recipharm AB: Announcement from the nomination committee concerning the Annual General Meeting 2015 (Businesswire)
27.02.15	Change in the total number of shares and votes in Recipharm AB (publ) (Businesswire)
19.02.15	Recipharm AB: Full-Year-report January-December 2014 (Businesswire)
16.02.15	Recipharm AB: Invitation to Presentation of Recipharm’s Full-Year-Report for 2014 on 19 February 2015 (Businesswire)
30.01.15	Change in the Total Number of Shares and Votes in Recipharm AB (Publ) (Businesswire)
22.01.15	Recipharm Releases the Lock-up on 815,000 B-Shares Related to Shares to Be Issued upon Conversion of Convertible Bonds (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Nestle	85.10	3.35 %	K V
Novartis	98.15	1.54 %	K V
Roche Hldg G	298.40	1.05 %	K V
Givaudan	3’927.00	1.00 %	K V
Sika	237.80	0.85 %	K V
CieFinRichemont	180.35	0.14 %	K V
Swiss Re	138.30	-0.04 %	K V
Lonza Grp	583.60	-0.10 %	K V
ABB	52.26	-0.19 %	K V
Holcim	94.36	-0.49 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Recipharm AB (B)

Aktien Top/Flop

Meistgelesene Nachrichten